Clinical Principle Treatment Categories for IC/BPS Behavioral/Non-pharmacologic Treatments Patients should be educated about normal bladder function, what is known and not known about IC/ BPS, the benefits versus risks/burdens of the available treatment alternatives, the fact that no single treatment has been found effective for the majority of patients, and the fact that acceptable symptom control may require trials of multiple therapeutic options (including combination therapy) before it is achieved
Emerging research including new guidance from the InfantRisk Center suggests that the biggest concern during breastfeeding may not be medication transfer into breast milk , but whether the parent is able to consume enough calories and nutrients to support milk production
Continuous chromatography may offer a future solution
B12 deficiency can lead to serious complications including anaemia and irreversible nerve damage if left untreated
Oxidative stress significantly contributes to the development and advancement of gastric cancer by causing DNA damage and impacting various signaling pathways
[1] Medications like pseudoephedrine, anticholinergics, and calcium channel blockers may worsen symptoms